Synthesis and Dual D2 and 5-HT1A Receptor Binding Affinities of 7-piperazinyl and 7-piperidinyl-3,4-dihydroquinazolin-2(1H)-ones

被引:9
作者
Ullah, Nisar [1 ]
机构
[1] King Fahd Univ Petr & Minerals, Dept Chem, Dhahran 31261, Saudi Arabia
关键词
D-2; receptor; 5-HT1A receptor; 7-Piperazinyl and piperidinyl-3,4-dihydroquinazolin-2(1H)-ones; Schizophrenia; Structure-activity relationship; ANTIPSYCHOTIC AGENTS; AGONIST PROPERTIES; ADOPRAZINE SLV313; SEROTONIN; 5-HT1A; NEW-GENERATION; SCHIZOPHRENIA; DOPAMINE; PROFILE; RAT; ACTIVATION;
D O I
10.2174/15734064113096660046
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new 7-piperazinyl and 7-piperidinyl-3,4-dihydroquinazolin-2(1H)-ones has been synthesized. The described compounds are structurally related to adoprazine, a potential atypical antipsychotic bearing potent D-2 receptor antagonist and 5-HT1A receptor agonist properties. Suitably modified aryl bromides were prepared and condensed with tert-butyl piperazine-1-carboxylate to afford the advanced intermediate piperazinyl-3,4-dihydroquinazolin-2(1H)-one. Likewise Suzuki-Miyaura cross-coupling reaction of cyclic vinyl boronate with appropriate aryl bromides rendered piperidinyl-3,4-dihydroquinazolin-2(1H)-one. The reductive amination of the piperazinyl and piperidinyl-3,4-dihydroquinazolin- 2(1H)-ones with suitably designed biarylaldehydes accomplished the synthesis of these title compounds. The described compounds were screened for D-2 and 5-HT1A receptors binding affinities. The structure-activity relationship studies revealed that cyclopentenylpyridine and cyclopentenylbenzyl groups contribute significantly to the dual D-2 and 5-HT1A receptor binding affinities of these compounds.
引用
收藏
页码:484 / 496
页数:13
相关论文
共 25 条
[1]   Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics:: Frontocortical dopamine and hippocampal serotonin release in rat brain [J].
Assié, MB ;
Ravailhe, V ;
Faucillon, V ;
Newman-Tancredi, A .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (01) :265-272
[2]  
Bakthavatchatam R., 2003, PCT INT APPL
[3]   The 5-HT1A receptor in schizophrenia:: a promising target for novel atypical neuroleptics? [J].
Bantick, RA ;
Deakin, JFW ;
Grasby, PM .
JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (01) :37-46
[4]   SYNTHESIS OF ANTHRANILONITRILES BY FRAGMENTATION OF ISATIN OXIME TRIFLATES [J].
CAMPBELL, JB ;
DAVENPORT, TW .
SYNTHETIC COMMUNICATIONS, 1989, 19 (13-14) :2255-2263
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]   Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities [J].
Cuisiat, Stephane ;
Bourdiol, Nathalie ;
Lacharme, Vincent ;
Newman-Tancredi, Adrian ;
Colpaert, Francis ;
Vacher, Bernard .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) :865-876
[7]  
FARGIN A, 1989, J BIOL CHEM, V264, P14848
[8]  
Goff D. C., 2003, SCHIZOPHRENIA, P573
[9]   THE HYDROGENATION OF NITRILES TO PRIMARY AMINES [J].
GOULD, FE ;
JOHNSON, GS ;
FERRIS, AF .
JOURNAL OF ORGANIC CHEMISTRY, 1960, 25 (09) :1658-1660
[10]   Serotonergic approaches in the development of novel antipsychotics [J].
Jones, Caidin A. ;
McCreary, Andrew C. .
NEUROPHARMACOLOGY, 2008, 55 (06) :1056-1065